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Summary 
Transgenic mice expressing self major histocompatibility complex (MHC) class I (H-2K  b) anti- 
gen solely in lymphoid cell lineages do not acquire tolerance to H-2K  b expressed on skin grafts. 
H-2Kb-specific cytotoxic T  cell responses were completely abrogated in these mice, even after 
they had  rejected skin  grafts.  Moreover,  thymocytes expressing T  cell receptors that  confer 
H-2K  b reactivity on cytotoxic CD8 + T  cells were eliminated. The ability to reject grafts corre- 
lated with the presence of a novel population of H-2Kb-reactive CD4 + T  cells. At least some 
of these CD4 + T  cells recognize peptides derived from H-2K  b by processing. We conclude that 
selfMHC I antigens induce tolerance in the CD8 T  cell compartment via negative selection when 
expressed exclusively by lymphoid cells.  In contrast, tolerance to MHC class II-restricted self 
peptides derived by processing of such MHC I antigens is not induced in the CD4 T  cell com- 
partment.  This suggests that effective transfer of self antigens from lymphoid cells to MHC 
II-positive cells  that  can  process and  present  them as  self peptides to  thymocytes or CD4  + 
T  cells does not take place in vivo. Thus, sequestration of self antigens and MHC II molecules 
in distinct cell types in the thymic microenvironment allows potentially autoreactive and func- 
tionally competent CD4 + T  cells that recognize cryptic MHC II-restricted selfpeptides to ma- 
ture into the peripheral T  cell repertoire under normal physiological circumstances. 
S 
elf tolerance is induced in the T  cell compartment by a 
number of mechanisms (1-4).  The most effective tolero- 
genic  mechanism  is  clonal  deletion  of self-reactive  thy- 
mocytes, but the  effectiveness of this  mechanism depends 
on whether  thymocytes are  exposed to  self antigens.  Self 
antigens must be expressed in thymus or transferred to thy- 
mic APC from "producer" ceils in peripheral tissues.  How- 
ever,  different APC  may present  distinct  peptides derived 
from the same protein because (a) the route of antigen deliv- 
ery; (b) the mechanism of antigen uptake (for extracellular 
proteins),  and  (c)  differential biochemical processing path- 
ways may all  influence  peptide  presentation.  These  issues 
are particularly important when considering how tolerance 
is  acquired  in  the  CD4  T  cell  compartment because few 
cell  types  express  MHC  II constitutively  in  vivo.  In  es- 
sence, self antigens not expressed by MHC II-positive thy- 
mic  cells  are  sequestered  because  peptides  derived  from 
them  cannot  be  presented  directly  to  thymocytes in  the 
context of MHC II. Self antigens in this category must be 
transferred  to  MHC  II-positive cells  and  processed  into 
peptides that associate with MHC II. Failure to deliver self 
antigens  from MHC  II-negative producer  cells  to  MHC 
II-positive APC  would  render  self peptides  invisible,  or 
cryptic, to the CD4 T  cell compartment (5, 6). 
Intercellular transfer of some self antigens occurs via pas- 
sive  mechanisms.  For  example,  complement factor C5,  a 
blood-borne protein,  is internalized,  by thymic MHC  II- 
positive  dendritic  cells  (DC)  (7).  Presumably,  cell-associ- 
ated proteins cannot be transferred unless there is intimate 
cell-cell cocntact or cell destruction allowing neighboring 
MHC II-positive APC to internalize cell contents. This is 
an  attractive  scenario  for  murine  thymocytes  (MHC  II 
negative)  because  large  numbers  of thymocytes  are  en- 
gulfed by thymic macrophages after, or before, their death 
by apoptosis (8). 
To investigate this issue,  we used a set of transgenic (Tg) 
mice that express the murine  H-2K  b MHC  I gene exclu- 
sively in lymphoid ceils (9,  10).  This provides a unique op- 
portunity to investigate whether tolerance is induced in the 
CD4  T  cell compartment by a  cell-associated self antigen 
expressed only by MHC II-negative cells in the thymus. In 
this report, we describe the tolerance status of the CD4 and 
CD8 T  cell compartments in such mice. 
Materials and Methods 
Mice.  Mice were bred in a specific pathogen-flee facility (Na- 
tional  Institute  for Medical  Research  [NIMP.]).  CD2Kb-3 -  (9, 
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TCIK-Tg  mice  expressing  two  different  clonotypic  receptors 
that confer H-2K  b recognition on CD8 + T cells (BM3 and DES) 
have been described previously (10,  12). 
Skin Grafts.  Skin grafts from CBK donor mice were applied 
to CD2Kb-Tg or CBA/Ca recipients using standard procedures 
(13).  Plaster casts protecting graft beds were removed 10 d after 
grafting, and grafts were inspected daily for signs of rejection. 
CHofluorimetricAnalyses.  lff'  thymocytes  were  stained  with 
biotinylated MV3  (anti-H-2K  b) antibody (14) and developed with 
streptavidin-PE (Biogenesis, Poole, UK). Thymocytes were gated, 
and selected events were displayed as histograms using FACSplot 
software  (NIMR  Computing  Division)  using  a  FACScan  | 
(Becton Dickinson & Co., Mountain View, CA) cytofluorimeter. 
Thymocytes from  DES  TCP,-Tg  mice  or  [DES  ￿  CD2Kb-4] 
double-Tg mice  were  stained with  anti-CD8-FITC  and  anti- 
CD4-PE as described previously (10). 
Generation of DC.  DC-enriched cell suspensions from  CBK 
and CBA mice were prepared by culturing bone marrow in the 
presence of GM-CSF (10,  12, 15). 
Bioassayfor H-2I~' Expression on DC.  4  ￿  lff' LN cells from 
BM3  TCP,,-Tg  mice  (12)  were  incubated with  4  ￿  10  6 bone 
marrow-derived DC  for  5  d.  IFN-'y release was  estimated by 
ELISA assay (12). 
Cytotoxicity Assays.  CD2Kb-Tg mice were injected subcuta- 
neously with 107 irradiated splenocytes from CBK mice. After 2 wk, 
splenocytes from primed mice were cultured with irradiated CBK 
splenocytes for 5 d in vitro (9).  Responder cells were harvested 
and incubated, in triplicate, with EL4 (H-2  b) target cells in the ra- 
tios shown (see Fig. 3) for 3 h. 25 Ixl ofsupernatant was harvested 
from each well, and specific release of 5~Cr (Amersham, Amer- 
sham, UK) was determined (16). 
T Cell Prolferation Assays.  Proliferation assays (9) were set up 
and harvested after 4 d with the following modifications. LN re- 
sponder cells were obtained from naive CD2Kb-Tg mice or from 
CD2Kb-Tg  mice  after  they  had  rejected  CBK  skin  grafts 
(primed).  2.5  ￿  l0  s  responder cells  were  stimulated with  I0  ~ 
bone  marrow-derived DC  in  flat-bottomed 96-well plates and 
cultured  in  medium  containing  1%  mouse  serum.  Cells  were 
pulsed with 1 IxCi [3H]thymidine (Amersham) for 8 h before har- 
vesting. In some cases, anti-CD4 antibody (GK1.5,  TIB  207,  a 
gift from Dr. R.  Zamoyska, NIMR)  was added. Synthetic pep- 
tide Kb[80-92]  (YWERETQKAKGNE; based on the 61-69 kb 
peptide described in reference 17) was made by the NIM1K Pep- 
tide Synthesis Service. Peptide was added to standard proliferation 
assays in  the  amounts  indicated. All assays were  carried out  in 
triplicate. 
Results 
Expression of H-2I~' in CD2I~'-Tg Mia'.  CD2Kb-Tg  mice 
carry  a  transgene  in  which  transcriptional  promoter  ele- 
ments from the human CD2 gene are joined to the H-2K  L' 
structural  gene  (9).  Mice  from  three  sublines  (CD2Kb-3, 
CD2K6-4,  CD2Kb-11)  differ only in transgene copy num- 
ber and chromosomal integration sites because oocytes from 
an inbred strain (CBA/Ca) were used to make CD2Kb-Tg 
mice  by  DNA  microinjection.  The  CD2K  b  transgene 
drives  H-2K  6  expression  in  lymphoid  cell  lineages  in  all 
CD2Kb-Tg mice.  Mature B  and  T  lymphocytes (data not 
shown) and thymocytes (Fig. 1 A) express H-2K  b. CD2K b- 
Tg thymocytes express "~  times more  H-2K  b than  thy- 
mocytes  from  non-Tg  C57BL/10  (H-2  b)  mice.  Myeloid 
cells (DC  and  macrophages)  from  CD2Kb-4  and  CI)2K  b- 
11 mice do not express H-2K  b as determined by cytofluori- 
metric analyses (data not shown), whereas myeloid cells from 
CD2Kb-3  mice  express H-2K  6 (10).  Results from  a  more 
sensitive, T  cell-dependent bioassay for H-2K  b expression 
(12)  confirm that bone marrow-derived DC from CD2Kb-4 
or CD2KB-11  mice express no detectable H-2K  b (Fig. 1 B). 
Similar results were obtained when stimulators used in this 
bioassay  were  cultured  DC  or  macrophages  originating 
from spleen or thymus (18). These results show that H-2W  ~ 
is  expressed  at  high  level  in  lymphoid cell lineages in  all 
sublines of CD2Kb-Tg mice but that expression in myeloid 
cell lineages occurs only in mice of the CD2KU-3 subline. 
Tolerance Status  cf CD2I~'  T  2 Mice.  Tolerance  to  H-2K  t~ 
was  assessed  by  grafting  CD2Kb-Tg  mice  with  tail  skin 
from  CBK-Tg mice  (11).  CBK mice express H-2K  b in all 
cells because they carry a transgene that is a subclone of the 
CD2Kb-3  CD2Kb_4  CD2K b- 11 
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Figure  1.  H-2K  b  expression by 
thymocytes and  DC  from CI)2K  b 
mice. (A) Histograms show H-2K b- 
specific antibody staining profiles on 
thymocytes froln CD2K  t' (solid lira's) 
or CBA mice (dotted lines). Markers 
show the relative level ofH-2K  b ex- 
pression on  PBL  from C57BL/10 
mice.  (/3)  IFN-'y  release when 
H-2Kb-specific, CI)8 + T cells from 
BM3  TCIK-Tg mice  (1(1) after co- 
culture with DC from CD2K  b (O). 
CBA ([]), or C57BL/10 (I) mice. Table  1.  Rejection  of Skin Grafts by CD2I~'-Tg Mice 
Mean 
Recipient  Donor  Rejected/total  survival time  Range 
d 
CBA/Ca  CBK  4/4  16  14-20 
CD2Kb-3  CBK  0/8  >100  - 
CD2Kb-4  CBK  6/7  43  23-84 
CD2Kb-ll  CBK  7/11  27  13-55 
entire  H-2K  b gene  including  the  H-2  promoter.  Conse- 
quently,  the  only difference between  donor CBK and re- 
cipient  CD2Kb-Tg mice  is  the  pattern  of H-2K  u expres- 
sion.  As was  found previously  (9),  CD2Kb-3  mice  accept 
CBK grafts (Table  1). Even though H-2K  b is a self antigen 
expressed  at  high level by lymphoid cells  from CD2Kb-4 
and CD2Kb-11  mice,  most of these mice reject  CBK skin 
grafts.  Thus,  most CD2Kb-4 and  CD2Kb-11  mice are not 
tolerized  to  H-2K  b,  and  we  conclude  that  expression  of 
H-2K  b solely in lymphoid cells  is not sufficient to generate 
tolerance to H-2K  b. 
CBK skin grafts survived much longer on CD2Kb-4 and 
CD2Kb-11  recipients  than  on  CBA  recipients  (Table  1). 
Grafts on CD2Kb-4 and CD2Kb-11  recipients had unusual 
appearances  before  rejection  in  that  they  became  dehy- 
drated,  shrank  slowly in size,  and were  not shed.  In con- 
trast,  grafts  rejected  by  CBA  recipients  quickly  became 
necrotic  and  were  shed,  as  is  normally  observed  when 
MHC-mismatched  grafts  are  rejected.  Qualitative  differ- 
ences  in  effector cells  and/or  their  relative  frequencies  in 
recipient mice could explain these discrepancies. 
H-2I~'-specific CD8 + T  Cells Are Eliminated in CD2I~'  Tg 
Mice.  The fate of H-2Kb-reactive thymocytes in CD2K  b 
mice was examined by intercrossing CD2Kb-Tg mice with 
TCR-Tg  mice  (10).  The  DES  TCIL  clonotype  confers 
H-2K  b reactivity  because  the  DES  TC1K-ix  and  TCR-[3 
transgenes  were  derived  from  an  allo-(H-2Kb)-reactive, 
CD8 + T  cell clone (D&ir6; see reference  19). Thymocytes 
from [DES  X  CD2Kb-4] double-Tg mice were eliminated 
efficiently and at an early stage in development, because the 
total number ofthymocytes was substantially reduced (~90%), 
and  virtually  all  immature  CD4+CD8 +  thymocytes were 
eliminated (Fig. 2). Almost all (87%)  remaining thymocytes 
were  immature  CD4-CD8-  thymocytes.  The  relatively 
high proportion (but low number)  of mature CD4+CD8 - 
thymocytes probably escape deletion because of rearrange- 
ments  of endogenous TCR  genes￿9 Almost identical  results 
were  obtained  when  CD2Kb-3  mice  were  intercrossed 
with BM3 or DES TCR-Tg  mice (10).  Thus,  thyrnocytes 
that  recognize native  cell surface-associated  H-2K  b mole- 
cules are eliminated in the thymus of CD2Kb-Tg mice. 
More  general  tests  for  T  cells  that  respond  to  H-2K  b 
were  carried  out  by  measuring  cytotoxicity generated  in 
vitro after coculturing T  cells from CD2Kb-Tg mice with 
irradiated  stimulator  cells  from  CBK  mice.  Splenocytes 
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Figure  2.  Elimination of H-2Kb-reactive thymocytes in  CD2Kb-4 
mice. Thymocytes from DES TCR-Tg mice (10) or [DES X CD2Kb-4] 
double Tg mice were stained with anti-CD4 (vertical axis) and anti-CD8 
(horizontal axis) antibodies. 60-80 ￿  10  ~' (DES) and 9-10 X 106 (DES X 
CD2Kb-4). thymocytes were obtained. Results shown are representative 
of several experiments. 
from CD2Kb-4  or CD2Kb-11  mice that had been immu- 
nized  with  CBK  splenocytes  before  setting  up  MLC  did 
not lyse target cells  expressing H-2K  b at levels above back- 
ground  (Fig.  3),  whereas  T  cells  from  immunized  CBA 
mice  lysed  these  targets  efficiently.  H-2Kb-specific  cyto- 
toxicity was not detected when responder T  cells  from na- 
ive CD2KB-Tg mice or CD2KB-Tg mice that had rejected 
CBK skin grafts were tested (data not shown).  Thus, cyto- 
toxic  T  cell  responses  were  completely  abrogated  in 
CD2KB-4 and CD2KB-11  mice,  even after in vivo immu- 
nization  against  H-2K  b,  and  we  conclude  that  allo-(H- 
2Kb)-reactive T  cells  (mostly CD8 +) are absent in CD2K  b- 
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Tg mice. This may occur because thymocytes can present 
native (i.e.,  cell associated)  H-2K  b to  other thymocytes in 
CD2Kb-Tg mice (10, 20). 
H-2I~  Peptide-specific  CD4 +  T  Cells  Are  Present  in 
CD2I~  Tg Mice.  H-2Kb~pecific T  cell proliferation was 
detected  when  LN  cells  from  CD2Kb-4  (Fig.  4)  or 
CD2Kb-ll  (data  not  shown)  mice  were  stimulated with 
cultured DC derived from CBK bone marrow. However, 
this response was detected only if LN cells were obtained 
from mice  that  had  previously rejected a  CBK skin graft 
(Fig.  4  A)  or  had  been immunized by injection of CBK 
splenocytes (data  not shown). Proliferative responses were 
abrogated completely by including anti-CD4 mAb in the 
culture medium (Fig.  4  B).  This shows that  H-2Kb-reac  - 
tive CD4 + T  cells are present in CD2Kb-4 and CD2K6-11 
mice. 
Reasoning that H-2Kb-reactive CD4 + T  cells might rec- 
ognize processed H-2K  b peptides presented on selfMHC II 
molecules  (H-2A  k  or  H-2Ek),  we  synthesized an  H-2K  b 
peptide  (Kb[80-92])  that  binds  to  H-2A  k molecules  and 
stimulates proliferation of CD4 + T  cells in CBA mice (17). 
Furthermore, this peptide is produced naturally from native 
H-2K  b protein in CBA mice since peptide-specific T  cell 
responses were  induced after immunization of CBA mice 
with splenocytes from B10  mice  (17).  T  cells from naive 
(unprimed) CD2Kb-4 and CD2Kb-11 mice proliferated in 
a dose-dependent manner when cocultured with CBA DC 
pulsed with Kb[80-92] peptide (Fig. 4  C). These responses 
were comparable with responses made by control CBA mice 
to the same peptide. Thus, at least some of the H-2Kb-spe  - 
cific  CD4 +  T  cells  present  in  CD2Kb-4  and  CD2Kb-ll 
mice recognize H-2K  b peptides that bind to selfMHC II. 
Discussion 
One explanation for the failure of lymphoid cells to in- 
duce tolerance in the CD4 T  cell  b  compartment of CD2K -4 
2 
0 
Peptide  (nM) 
Figure 4.  Assays  for H-2Kb-specific  T cell proliferation.  (A) LN T cells 
from CD2Kb-4 mice that had rejected skin grafts from CBK (CI)2Kt'-4  - 
primed), naive CD2Kb-4, and CBA mice were stimulated  with DC from 
CBK (solid bars) or CBA (striped bars) mice. (/3) LN T cells from CBA 
(open bars) or immunized CD2Kb-4 (solid bars) mice were stimulated  with 
DC from CBK mice in the presence of different amounts of hybridoma 
culture supernatant  containing  anti-CD4 mAb. (C) LN T cells from CBA 
(open bars), CD2Kb-4 (solid bars), or CD2K6-11 (striped bars) mice were 
stimulated with CBA DC pulsed with Kb[80-92] peptide. All cultures 
were carried out in triplicate, and the results shown are representative of 
three separate experiments. Error bars show the standard deviation.  Verti- 
cal axes show CPM X 10  4. 
and  CD2Kb-11  mice  is  that  thymocytes  cannot  present 
MHC  II-restricted peptides  because  they  do  not  express 
MHC  II.  However,  tolerance to  serum proteins, such  as 
complement factor C5, is induced in the CD4 T  cell com- 
partment  after  C5  uptake  and  processing before  peptide 
presentation on thymic MHC  II-positive cells, which in- 
duces clonal deletion of C5-reactive thymocytes (7). Transfer 
of proteins between cells may provide a general mechanism 
by which  thymocytes are  exposed  to  MHC  II-restricted 
peptides that originate from self antigens expressed only by 
MHC  II-negative  cells.  Protein  transfers  between  cells 
might occur by passive uptake of antigen (as for C5) or af- 
ter cell destruction and consequent release of self antigens 
into local microenvironments from which they are  inter- 
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T  cells by MHC  II-positive cells. This scenario may occur 
during necrosis, when dying cells release their contents  di- 
rectly into the surrounding  microenvironment  (21).  How- 
ever, most thymocytes die by apoptosis, during which cells 
remain  intact  until  scavenger macrophages  engulf and  de- 
stroy them (8). 
We conclude that there is no effective mechanism for trans- 
ferring  H-2K  b molecules  between  thymocytes  and  MHC 
II-positive cells to present MHC  II-restricted H-2K  b pep- 
tides  because  H-2K  b specific  CD4 +  T  cells are  present  in 
CD2Kb-4 and CD2Kb-11  mice. This provides unequivocal 
evidence  that a  cell-associated self antigen  expressed solely 
by lymphoid  cells does  not  tolerize  the  CD4  T  cell  com- 
partment  under  normal  physiological  conditions  in  vivo. 
This  finding  should  be  generally  applicable  to  other  self 
proteins that are expressed only by cells that do not express 
MHC  II constitutively in vivo unless special factors prevent 
transfers of cell surface-associated proteins from thymocytes 
to  thymic  MHC  II-positive  cells.  Under  normal  physio- 
logical  conditions,  proteins  sequestered  inside  cells  that 
produce them would be even less likely to be transferred to 
other  cells  than  proteins  such  as  H-2K  b, which  is located 
on the  external  surface of the  cell membrane.  If our find- 
ings are generally applicable, we predict that large numbers 
of self peptides that could be generated by processing of self 
antigens  and that could bind to self MHC  II are not avail- 
able for tolerance induction in the CD4 T  cell compartment 
because of (a)  segregated (i.e., tissue-specific)  expression of 
self antigens  and MHC  II; (b) intracellular  compartmental- 
ization of processed peptides and newly expressed MHC  II, 
or (c) a combination of these alternatives. Exposure of such 
"cryptic" selfpeptides could lead to functional activation of 
mature  CD4 +  T  cells,  as  was  observed  in  CD2Kb-4  and 
CD2Kb-11  mice  grafted with  CBK  skin.  Altered  physio- 
logical conditions that lead to changes in normal patterns of 
self protein  or self MHC  II expression  may provide novel 
opportunities for transferring proteins between cells or pre- 
senting  previously  cryptic  self peptides  to  T  cells  (5,  22, 
23).  In  effect,  rejection  of CBK  skin  grafts by  CD2Kb-4 
and  CD2Kb-11  mice  mimics  such  circumstances  because 
there  is no  genetic  (i.e.,  structural)  difference between  re- 
cipient  and  donor  tissues.  Cryptic  H-2K  b peptides  are  ei- 
ther  displayed  naturally  by cells  in  the  CBK  graft  and/or 
are generated as a result of inflammation after surgery. 
We assume that expression of H-2K  b by myeloid cells, as 
well  as  lymphoid  cells  in  CD2Kb-3  mice,  explains  why 
these mice do not reject CBK skin grafts. Presumably,  co- 
expression  of H-2K  b  and  MHC  II  molecules  by  thymic 
myeloid cells allows these cells to display processed H-2K  b 
peptides that remain sequestered in CD2Kb-4 and CD2K  b- 
11 mice. There is substantial evidence that peptides derived 
from intracellular proteins can associate with MHC  II mol- 
ecules synthesized in the same cells (24-27). 
The role and status of B cells in CD2Kb-4 and CD2Kb-11 
mice is of interest because they coexpress H-2K  b and MHC 
II in CD2Kb-Tg mice. B  cells tolerize naive, but not anti- 
gen-experienced,  CD4 +  T  cells in vivo creating  an unre- 
sponsive state  (anergy)  in T  cells  (28).  Nevertheless,  naive 
B  cells  and  activated B  cell blasts  are  relatively inefficient 
APCs for T  cell activation because they do not express ad- 
hesion  and  costimulatory  molecules  such  as  CD54  and 
CD80  (26).  Thus,  even if B  cells  display H-2Kb-peptide/ 
MHC  II complexes,  they may not influence  the  tolerance 
status  of CD4 +  T  cells  that  recognize  these  complexes. 
However, it will be interesting to examine whether the re- 
lationship  between  H-2K  b peptide-specific  CD4 +  T  cells 
and B  cells in CD2Kb-4 and CD2Kb-11  mice is altered af- 
ter graft rejection. 
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